Mosby's 2014 Nursing Drug Reference (225 page)

BOOK: Mosby's 2014 Nursing Drug Reference
13.57Mb size Format: txt, pdf, ePub

Canada only   Side effects:
italics
= common;
bold
= life-threatening   
Nurse Alert

isoflurophate
ophthalmic

See
Appendix B

 

isoniazid (Rx)

(eye-soe-nye′a-zid)

Isotamine

Func. class.:
Antitubercular

Chem. class.:
Isonicotinic acid hydrazide

ACTION:

Bactericidal interference with lipid, nucleic acid biosynthesis

USES:

Treatment, prevention of TB

CONTRAINDICATIONS:

Hypersensitivity

 

Black Box Warning:

Acute hepatic disease

Precautions:
Pregnancy (C), renal disease, diabetic retinopathy, cataracts, ocular defects, IV drug users, >35 yr, postpartum, HIV, neuropathy

 

Black Box Warning:

Alcoholism, females (African descent/Hispanic patients)

DOSAGE AND ROUTES
Calculator

• Adult/adolescent with/without HIV: PO/IM
5 mg/kg/day ≤300 mg/day or 15 mg/kg 2-3×/wk, max 900 mg 2-3×/wk

• Child/infant with HIV: PO/IM
10-15 mg/kg/day, max 300 mg/day

Available forms:
Tabs 100, 300 mg; inj 100 mg/ml

Administer:
PO route

• 
PO with meals to decrease GI symptoms; better to take on empty stomach 1 hr before or 2 hr after meals

IM route

• 
IM deep in large muscle mass; massage; rotate inj site; warm inj to room temp to dissolve crystals

SIDE EFFECTS

CNS:
Peripheral neuropathy, dizziness
, memory impairment,
toxic encephalopathy, seizures,
psychosis, slurred speech

EENT:
Blurred vision, optic neuritis

GI:
Nausea, vomiting
, epigastric distress,
jaundice, fatal hepatitis

HEMA:
Agranulocytosis, hemolytic, aplastic anemia, thrombocytopenia, eosinophilia, methemoglobinemia

Hypersensitivity:
Fever, skin eruptions, lymphadenopathy, vasculitis

MISC:
Dyspnea, B
6
deficiency, pellagra, hyperglycemia, metabolic acidosis, gynecomastia, rheumatic syndrome, SLE-like syndrome

PHARMACOKINETICS

Metabolized in liver, excreted in urine (metabolites), crosses placenta, excreted in breast milk, half life 1-4 hr

PO:
Peak 1-2 hr

IM:
Peak 45-60 min

INTERACTIONS

Increase:
toxicity—tyramine foods, alcohol, cycloSERINE, ethionamide, rifampin, carBAMazepine, phenytoin, benzodiazepines, meperidine

Increase:
serotonin syndrome—SSRIs, SNRIs

Decrease:
absorption—aluminum antacids

Decrease:
effectiveness of BCG vaccine, ketoconazole

Drug/Food

• 
Do not give with high-tyramine foods, alcohol

Drug/Lab Test

Increase:
LFTs, bilirubin, glucose

Decrease:
platelets granulocytes

NURSING CONSIDERATIONS
Assess:

 

Black Box Warning:

Hepatic studies weekly: baseline in all patients, those >35 yr and all women should be monitored periodically; ALT, AST, bilirubin; increased test results may indicate hepatitis; hepatic status: decreased appetite, jaundice, dark urine, fatigue, those with fast acetylation (genetic) may metabolize product more than 5 times faster (black, Asian patients are at greater risk) some Caucasian patients; fatal hepatitis is at greater risk in black/Hispanic patients after birth

• 
Mental status often: affect, mood, behavioral changes; psychosis may occur

• 
Paresthesia in hands, feet

Evaluate:

• 
Therapeutic response: decreased symptoms of TB

Teach patient/family:

• 
That compliance with dosage schedule, duration is necessary; not to skip or double dose

• 
That scheduled appointments must be kept or relapse may occur

 
To avoid alcohol while taking product; may increase risk for hepatic injury

• 
That, if diabetic, to use blood glucose monitor to obtain correct result

 
To report weakness, fatigue, loss of appetite, nausea, vomiting, jaundice of skin or eyes, tingling/numbness of hands/feet

 

Black Box Warning:

Fatal hepatitis:
to notify prescriber immediately of yellow skin/eyes, dark urine, loss of appetite

TREATMENT OF OVERDOSE:

Pyridoxine

Canada only   Side effects:
italics
= common;
bold
= life-threatening   
Nurse Alert

isosorbide dinitrate (Rx)

(eye-soe-sor′bide)

Apo-ISDN
, Dilatrate-SR, Isochron, IsoDitrate, Isordil

isosorbide mononitrate (Rx)

Apo-ISMN
, Imdur

Func. class.:
Antianginal, vasodilator

Chem. class.:
Nitrate

Do not confuse:
Imdur
/Imuran/Inderal/K-Dur

ACTION:

Relaxation of vascular smooth muscle, which leads to decreased preload, afterload, which is responsible for decreasing left ventricular end-diastolic pressure, systemic vascular resistance, and reducing cardiac oxygen demand

USES:

Treatment, prevention of chronic stable angina pectoris

Unlabeled uses:
Diffuse esophageal spasm, heart failure (dinitrate)

CONTRAINDICATIONS:

Hypersensitivity to this product or nitrates; severe anemia, increased intracranial pressure, cerebral hemorrhage, acute MI

Precautions:
Pregnancy (C), breastfeeding, children, postural hypotension, MI, CHF, severe renal/hepatic disease

DOSAGE AND ROUTES
Calculator
Dinitrate

• Adult: PO
5-20 mg bid-tid initially, maintenance 10-40 mg bid-tid;
SL,
buccal 2.5-5 mg, may repeat q5-10min × 3 doses;
EXT REL
40-80 mg q8-12hr, max 160 mg/day

Mononitrate

• Adult: PO
(Monoket) 10-20 mg bid, 7 hr apart; (Imdur) initiate at 30-60 mg/day as a single dose, increase q3days as needed, may increase to 120 mg/day, max 240 mg/day

Available forms:
Dinitrate:
sus rel caps (SR) 40 mg, SR tabs 40 mg; tabs 5, 10, 20, 30, 40 mg; SL tabs 2.5, 5 mg;
mononitrate:
tabs (Monoket) 10, 20 mg; ext rel (Imdur) 30, 60, 120 mg

Administer:

• 
Do not break, crush, or chew sus rel caps, SL tabs

• 
After checking expiration date

• 
PO with 8 oz water on empty stomach

• 
SL tabs should be placed under the tongue until dissolved; avoid smoking, eating, drinking until dissolved

SIDE EFFECTS

CNS:
Vascular headache, flushing, dizziness
, weakness, faintness

CV:
Postural hypotension
, tachycardia,
collapse,
syncope, palpitations

GI:
Nausea, vomiting, diarrhea

INTEG:
Pallor, sweating, rash

MISC:
Twitching,
hemolytic anemia, methemoglobinemia,
tolerance

PHARMACOKINETICS
Dinitrate

Metabolized by liver, excreted in urine as metabolites (80%-100%)

PO:
Onset 15-30 min, duration 4-6 hr, half-life 5-6 hr

SUS REL:
Onset ≤4 hr, duration 6-8 hr

SL:
Onset 2-5 min, duration 1-4 hr, half-life 2 hr

Mononitrate

SUS REL:
Onset 30-60 min, peak 1-4 hr, duration 6-8 hr, half-life 5 hr

INTERACTIONS

 
Fatal hypotension: sildenafil, tadalafil, vardenafil, do not use together

Increase:
hypotension—β-blockers, diuretics, antihypertensives, alcohol, calcium channel blockers, phenothiazines

NURSING CONSIDERATIONS
Assess:

• 
Anginal pain:
duration, time started, activity being performed, character


 
Methemoglobinemia (rare):
Cyanosis of lips, nausea/vomiting, coma, shock, usually caused by high dose of product but may occur with normal dosing

• 
B/P, pulse, respirations during beginning therapy and periodically thereafter

• 
Tolerance if taken over long period, to prevent, allow intervals of 12-14 hr/day without product

• 
Headache, lightheadedness, decreased B/P; may indicate a need for decreased dosage, treat headache with OTC analgesics

Evaluate:

• 
Therapeutic response: decrease or prevention of anginal pain

Teach patient/family:

• 
To leave tabs in original container

• 
To avoid alcohol, OTC products unless approved by prescriber

• 
That product may cause headache; that taking with meals may reduce or eliminate headache; to take no later than 7
PM
(last dose)

• 
To avoid hazardous activities if dizziness occurs

• 
About the importance of complying with complete medical regimen

• 
To make position changes slowly to prevent orthostatic hypotension


 
Not to use with sildenafil, tadalafil, vardenafil with nitrates, may cause serious drop in B/P


 
Not to discontinue abruptly, may cause heart attack


 
To use at beginning of angina symptoms, may repeat every 15 mins; if no relief, seek medical attention immediately

Other books

Restraint (Xcite Romance) by Stein, Charlotte
Grey by Jon Armstrong
On Midnight Wings by Adrian Phoenix
On the Run by Tristan Bancks
Lenin's Kisses by Yan Lianke